Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy R Webb

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Current Atherosclerosis Reports|February 8, 2022
Correction to: High-Density Lipoproteins and Serum Amyloid A (SAA)Nancy R Webb
Current Atherosclerosis Reports|January 15, 2021
High-Density Lipoproteins and Serum Amyloid A (SAA)Nancy R Webb
Nature Medicine|October 9, 2008
Getting to the core of atherosclerosisNancy R Webb
Current Opinion in Lipidology|May 14, 2005
Secretory phospholipase A2 enzymes in atherogenesisNancy R Webb
Current Drug Targets|January 29, 2008
Macrophage-derived foam cells in atherosclerosis: lessons from murine models and implications for therapyNancy R Webb, Kathryn J Moore
Cardiovascular Drugs and Therapy|October 15, 2008
Biology of secretory phospholipase A2Boris B Boyanovsky, Nancy R Webb
Arteriosclerosis, Thrombosis, and Vascular Biology|June 24, 2006
Inflammation and atherosclerosis: Group IIa and Group V sPLA2 are not redundantFrederick C de Beer, Nancy R Webb
The Journal of Biological Chemistry|January 28, 2015
Ectopically expressed pro-group X secretory phospholipase A2 is proteolytically activated in mouse adrenal cells by furin-like proprotein convertases: implications for the regulation of adrenal steroidogenesisJoseph D Layne, Preetha Shridas, Nancy R Webb
The Journal of Biological Chemistry|July 7, 2018
High-density lipoprotein inhibits serum amyloid A-mediated reactive oxygen species generation and NLRP3 inflammasome activationPreetha Shridas, Maria C De Beer, Nancy R Webb
Arteriosclerosis, Thrombosis, and Vascular Biology|January 24, 2009
The capacity of group V sPLA2 to increase atherogenicity of ApoE-/- and LDLR-/- mouse LDL in vitro predicts its atherogenic role in vivoBoris Boyanovsky, Melissa Zack, Kathy Forrest, et al.
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Current Atherosclerosis Reports|February 8, 2022
Correction to: High-Density Lipoproteins and Serum Amyloid A (SAA)Nancy R Webb
Current Atherosclerosis Reports|January 15, 2021
High-Density Lipoproteins and Serum Amyloid A (SAA)Nancy R Webb
Nature Medicine|October 9, 2008
Getting to the core of atherosclerosisNancy R Webb
Current Opinion in Lipidology|May 14, 2005
Secretory phospholipase A2 enzymes in atherogenesisNancy R Webb
Current Drug Targets|January 29, 2008
Macrophage-derived foam cells in atherosclerosis: lessons from murine models and implications for therapyNancy R Webb, Kathryn J Moore
Cardiovascular Drugs and Therapy|October 15, 2008
Biology of secretory phospholipase A2Boris B Boyanovsky, Nancy R Webb
Arteriosclerosis, Thrombosis, and Vascular Biology|June 24, 2006
Inflammation and atherosclerosis: Group IIa and Group V sPLA2 are not redundantFrederick C de Beer, Nancy R Webb
The Journal of Biological Chemistry|January 28, 2015
Ectopically expressed pro-group X secretory phospholipase A2 is proteolytically activated in mouse adrenal cells by furin-like proprotein convertases: implications for the regulation of adrenal steroidogenesisJoseph D Layne, Preetha Shridas, Nancy R Webb
The Journal of Biological Chemistry|July 7, 2018
High-density lipoprotein inhibits serum amyloid A-mediated reactive oxygen species generation and NLRP3 inflammasome activationPreetha Shridas, Maria C De Beer, Nancy R Webb
Arteriosclerosis, Thrombosis, and Vascular Biology|January 24, 2009
The capacity of group V sPLA2 to increase atherogenicity of ApoE-/- and LDLR-/- mouse LDL in vitro predicts its atherogenic role in vivoBoris Boyanovsky, Melissa Zack, Kathy Forrest, et al.
Pageof 7